Burning Rock Biotech Limited
BNR
$4.60
-$0.10-2.13%
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.03% | -16.00% | -16.22% | -16.22% | -22.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.03% | -16.00% | -16.22% | -16.22% | -22.04% |
| Cost of Revenue | -10.60% | -13.01% | 3.22% | 3.22% | -14.51% |
| Gross Profit | 8.15% | -17.32% | -24.08% | -24.08% | -25.23% |
| SG&A Expenses | -54.57% | -28.07% | -22.62% | -22.62% | -26.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.78% | -27.60% | -21.36% | -21.36% | -25.62% |
| Operating Income | 78.17% | 36.37% | 24.72% | 24.72% | 27.98% |
| Income Before Tax | 79.40% | 37.42% | 26.00% | 26.00% | 28.75% |
| Income Tax Expenses | -54.75% | -59.32% | -44.56% | -44.56% | -- |
| Earnings from Continuing Operations | 79.33% | 37.47% | 26.17% | 26.17% | 28.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.33% | 37.47% | 26.17% | 26.17% | 28.57% |
| EBIT | 78.17% | 36.37% | 24.72% | 24.72% | 27.98% |
| EBITDA | 96.10% | 44.02% | 29.86% | 29.86% | 37.15% |
| EPS Basic | 79.51% | 37.57% | 26.18% | 26.18% | 27.46% |
| Normalized Basic EPS | 79.58% | 37.51% | 26.02% | 26.02% | 27.65% |
| EPS Diluted | 79.51% | 37.57% | 26.18% | 26.18% | 27.46% |
| Normalized Diluted EPS | 79.58% | 37.51% | 26.02% | 26.02% | 27.65% |
| Average Basic Shares Outstanding | 0.88% | 0.15% | 0.02% | 0.02% | -1.52% |
| Average Diluted Shares Outstanding | 0.88% | 0.15% | 0.02% | 0.02% | -1.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
